|Day's Range||1.00 - 1.12|
|52 Week Range||0.52 - 3.15|
|PE Ratio (TTM)||-0.95|
|Earnings Date||Aug 1, 2017 - Aug 7, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||4.75|
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., June 01, 2017-- Ocera Therapeutics, Inc., today announced the dosing of the first patients in Part Two of a Phase1/Phase 2 a clinical trial of oral ...
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., May 26, 2017-- Ocera Therapeutics, Inc., a clinical stage biopharmaceutical company focused on acute and chronic liver diseases, today announced that ...
Q1 2017 Ocera Therapeutics Inc Earnings Call